Exposure to silver nanoparticles inhibits selenoprotein synthesis and the activity of thioredoxin reductase

Environmental Health Perspectives

Volumn 120, Issue 1, 2012, Pages 56-61

  Srivastava, Milan ^a   Singh, Sanjay ^a   Self, William T ^a  

^a UNIVERSITY OF CENTRAL FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Nanotoxicology; Proliferation; Selenium; Selenocysteine; Silver nanoparticles; Thioredoxin reductase

Indexed keywords

SELENIUM; SELENOPROTEIN; SILVER NANOPARTICLE; THIOREDOXIN REDUCTASE;

ARTICLE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EXPOSURE; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; KERATINOCYTE; LUNG ALVEOLUS EPITHELIUM; METABOLISM; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SYNTHESIS;

RATTUS;

EID: 84930479214     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1103928     Document Type: Article

References (50)

1. Aaseth J, Olsen A, Halse J, Hovig T. 1981. Argyria-tissue deposition of silver as selenide. Scand J Clin Lab Invest 41(3):247-251.
2. Ahamed M, Posgai R, Gorey TJ, Nielsen M, Hussain SM, Rowe JJ. 2010. Silver nanoparticles induced heat shock protein 70, oxidative stress and apoptosis in Drosophila melanogaster. Toxicol Appl Pharmacol 242(3):263-269.
3. Arora S, Jain J, Rajwade JM, Paknikar KM. 2008. Cellular responses induced by silver nanoparticles: in vitro studies. Toxicol Lett 179(2):93-100.
4. Asharani PV, Hande MP, Valiyaveettil S. 2009. Anti-proliferative activity of silver nanoparticles. BMC Cell Biol 10:65; doi:10.1186/1471-2121-10-65 [Online 17 September 2009].
5. Bleehen SS, Gould DJ, Harrington CI, Durrant TE, Slater DN, Underwood JC. 1981. Occupational argyria; light and electron microscopic studies and X-ray microanalysis. Br J Dermatol 104(1):19-26.
6. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
7. Cha K, Hong HW, Choi YG, Lee MJ, Park JH, Chae HK, et al. 2008. Comparison of acute responses of mice livers to short-term exposure to nano-sized or micro-sized silver particles. Biotechnol Lett 30(11):1893-1899.
8. Chae YJ, Pham CH, Lee J, Bae E, Yi J, Gu MB. 2009. Evaluation of the toxic impact of silver nanoparticles on Japanese medaka (Oryzias latipes). Aquat Toxicol 94(4):320-327.
9. Cheng Q, Sandalova T, Lindqvist Y, Arner ES. 2009. Crystal structure and catalysis of the selenoprotein thioredoxin reductase 1. J Biol Chem 284(6):3998-4008.
10. Cox AG, Brown KK, Arner ES, Hampton MB. 2008. The thioredoxin reductase inhibitor auranofin triggers apoptosis through a Bax/Bak-dependent process that involves peroxiredoxin 3 oxidation. Biochem Pharmacol 76(9):1097-1109.
11. Du S, Liu H, Huang K. 2010. Influence of SelS gene silence on β-mercaptoethanol-mediated endoplasmic reticulum stress and cell apoptosis in HepG2 cells. Biochim Biophys Acta 1800(5):511-517.
12. Eriksson SE, Prast-Nielsen S, Flaberg E, Szekely L, Arner ES. 2009. High levels of thioredoxin reductase 1 modulate drug-specific cytotoxic efficacy. Free Radic Biol Med 47(11):1661-1671.
13. Gailer J, George GN, Pickering IJ, Madden S, Prince RC, Yu EY, et al. 2000. Structural basis of the antagonism between inorganic mercury and selenium in mammals. Chem Res Toxicol 13(11):1135-1142.
14. Gailer J, George GN, Pickering IJ, Prince RC, Younis HS, Winzerling JJ. 2002. Biliary excretion of [(GS)(2)AsSe](-) after intravenous injection of rabbits with arsenite and selenate. Chem Res Toxicol 15(11):1466-1471.
15. Gandin V, Fernandes AP, Rigobello MP, Dani B, Sorrentino F, Tisato F, et al. 2010. Cancer cell death induced by phosphine gold(I) compounds targeting thioredoxin reductase. Biochem Pharmacol 79(2):90-101.
16. Ganther HE. 1980. Interactions of vitamin E and selenium with mercury and silver. Ann N Y Acad Sci 355:212-226.
17. Ganyc D, Talbot S, Konate F, Jackson S, Schanen B, Cullen W, et al. 2007. Impact of trivalent arsenicals on selenoprotein synthesis. Environ Health Perspect 115:346-353.
18. Jackson-Rosario S, Cowart D, Myers A, Tarrien R, Levine RL, Scott RA, et al. 2009. Auranofin disrupts selenium metabolism in Clostridium difficile by forming a stable Au-Se adduct. J Biol Inorg Chem 14(4):507-519.
19. Jackson-Rosario SE, Self WT. 2010. Targeting selenium metabolism and selenoproteins: novel avenues for drug discovery. Metallomics 2(2):112-116.
20. Kawata K, Osawa M, Okabe S. 2009. In vitro toxicity of silver nanoparticles at noncytotoxic doses to HepG2 human hepatoma cells. Environ Sci Technol 43(15):6046-6051.
21. Kim S, Choi JE, Choi J, Chung KH, Park K, Yi J, et al. 2009. Oxidative stress-dependent toxicity of silver nanoparticles in human hepatoma cells. Toxicol In vitro 23(6):1076-1084.
22. Kim WY, Kim J, Park JD, Ryu HY, Yu IJ. 2009. Histological study of gender differences in accumulation of silver nanoparticles in kidneys of Fischer 344 rats. J Toxicol Environ Health A 72(21-22):1279-1284.
23. Korotkov KV, Kumaraswamy E, Zhou Y, Hatfield DL, Gladyshev VN. 2001. Association between the 15-kDa selenoprotein and UDP-glucose:glycoprotein glucosyltransferase in the endoplasmic reticulum of mammalian cells. J Biol Chem 276(18):15330-15336.
24. Kulthong K, Srisung S, Boonpavanitchakul K, Kangwansupamonkon W, Maniratanachote R. 2010. Determination of silver nanoparticle release from antibacterial fabrics into artificial sweat. Part Fibre Toxicol 7:8; doi:10.1186/1743-8977-7-8 [Online 1 April 2010].
25. Lankveld DP, Oomen AG, Krystek P, Neigh A, Troost-de Jong A, Noorlander CW, et al. 2010. The kinetics of the tissue distribution of silver nanoparticles of different sizes. Biomaterials 31(32):8350-8361.
26. Li PW, Kuo TH, Chang JH, Yeh JM, Chan WH. 2010. Induction of cytotoxicity and apoptosis in mouse blastocysts by silver nanoparticles. Toxicol Lett 197(2):82-87.
27. Lu J, Chew EH, Holmgren A. 2007. Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide. Proc Natl Acad Sci USA 104(30):12288-12293.
28. Massi D, Santucci M. 1998. Human generalized argyria: a submicroscopic and X-ray spectroscopic study. Ultrastruct Pathol 22(1):47-53.
29. Meno SR, Nelson R, Hintze KJ, Self WT. 2009. Exposure to monomethylarsonous acid (MMA(III)) leads to altered selenoprotein synthesis in a primary human lung cell model. Toxicol Appl Pharmacol 239(2):130-136.
30. Miura N, Shinohara Y. 2009. Cytotoxic effect and apoptosis induction by silver nanoparticles in HeLa cells. Biochem Biophys Res Commun 390(3):733-737.
31. Nordberg J, Arner ES. 2001. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic Biol Med 31(11):1287-1312.
32. Pfaffl MW. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29(9):e45; doi:10.1093/nar/29.9.e45 [Online 14 March 2001].
33. Powers CM, Badireddy AR, Ryde IT, Seidler FJ, Slotkin TA. 2010a. Silver nanoparticles compromise neurodevelopment in PC12 cells: critical contributions of silver ion, particle size, coating and composition. Environ Health Perspect 119:37-44.
34. Powers CM, Wrench N, Ryde IT, Smith AM, Seidler FJ, Slotkin TA. 2010b. Silver impairs neurodevelopment: studies in PC12 cells. Environ Health Perspect 118:73-79.
35. Prast-Nielsen S, Cebula M, Pader I, Arner ES. 2010. Noble metal targeting of thioredoxin reductase-covalent complexes with thioredoxin and thioredoxin-related protein of 14 kDa triggered by cisplatin. Free Radic Biol Med 49(11):1765-1778.
36. Prast-Nielsen S, Dexheimer TS, Schultz L, Stafford WC, Cheng Q, Xu J, et al. 2011. Inhibition of thioredoxin reductase 1 by porphyrins and other small molecules identified by a high throughput screening assay. Free Radic Biol Med 50(9):1114-1123.
37. Project on Emerging Nanotechnologies, Woodrow Wilson International Center for Scholars. 2010. Nanotechnology Consumer Product Inventory. Available: http://www.nanotechproject.org/inventories/consumer/ [accessed 1 May 2011].
38. Rahman MF, Wang J, Patterson TA, Saini UT, Robinson BL, Newport GD, et al. 2009. Expression of genes related to oxidative stress in the mouse brain after exposure to silver-25 nanoparticles. Toxicol Lett 187(1):15-21.
39. Roh JY, Sim SJ, Yi J, Park K, Chung KH, Ryu DY, et al. 2009. Ecotoxicity of silver nanoparticles on the soil nematode Caenorhabditis elegans using functional ecotoxicogenomics. Environ Sci Technol 43(10):3933-3940.
40. Samberg ME, Oldenburg SJ, Monteiro-Riviere NA. 2010. Evaluation of silver nanoparticle toxicity in skin in vivo and keratinocytes in vitro. Environ Health Perspect 118:407-413.
41. Santini C, Pellei M, Papini G, Morresi B, Galassi R, Ricci S, et al. 2011. In vitro antitumour activity of water soluble Cu(I), Ag(I) and Au(I) complexes supported by hydrophilic alkyl phosphine ligands. J Inorg Biochem 105(2):232-240.
42. Sasakura C, Suzuki KT. 1998. Biological interaction between transition metals (Ag, Cd and Hg), selenide/sulfide and selenoprotein P. J Inorg Biochem 71(3-4):159-162.
43. Sato S, Sueki H, Nishijima A. 1999. Two unusual cases of argyria: the application of an improved tissue processing method for X-ray microanalysis of selenium and sulphur in silver-laden granules. Br J Dermatol 140(1):158-163.
44. Scown TM, Santos EM, Johnston BD, Gaiser B, Baalousha M, Mitov S, et al. 2010. Effects of aqueous exposure to silver nanoparticles of different sizes in rainbow trout. Toxicol Sci 115(2):521-534.
45. Selvakannan PR, Swami A, Srisathiyanarayanan D, Shirude PS, Pasricha R, Mandale AB, et al. 2004. Synthesis of aqueous Au core-Ag shell nanoparticles using tyrosine as a pH-dependent reducing agent and assembling phase-transferred silver nanoparticles at the air-water interface. Langmuir 20(18):7825-7836.
46. Smith AD, Levander OA. 2002. High-throughput 96-well microplate assays for determining specific activities of glutathione peroxidase and thioredoxin reductase. Methods Enzymol 347:113-121.
47. Stadtman TC. 2000. Selenium biochemistry. Mammalian selenoenzymes. Ann N Y Acad Sci 899:399-402.
48. Talbot S, Nelson R, Self WT. 2008. Arsenic trioxide and auranofin inhibit selenoprotein synthesis: implications for chemotherapy for acute promyelocytic leukaemia. Br J Pharmacol 154(5):940-948.
49. Wagner PA, Hoekstra WG, Ganther HE. 1975. Alleviation of silver toxicity by selenite in the rat in relation to tissue glutathione peroxidase. Proc Soc Exp Biol Med 148(4):1106-1110.
50. Wu Y, Zhou Q, Li H, Liu W, Wang T, Jiang G. 2010. Effects of silver nanoparticles on the development and histopathology biomarkers of Japanese medaka (Oryzias latipes) using the partial-life test. Aquat Toxicol 100(2):160-167.